University of Michigan Medical School, 1301 Catherine St, Ann Arbor, MI, 48109, USA.
Assistant Clinical Professor, University of California, Davis 2315 Stockton Blvd, Sacramento, CA, 95817, USA.
Anaerobe. 2021 Aug;70:102384. doi: 10.1016/j.anaerobe.2021.102384. Epub 2021 May 23.
Testing for and incidence of Clostridioides difficile infection (CDI) was examined at a single center before and during the first surge of the COVID-19 pandemic. Incidence of CDI remained stable but testing statistically significantly decreased during the first surge despite an increase in antibiotic use. There were no new CDI-focused antimicrobial stewardship interventions introduced during this time.
在 COVID-19 大流行的第一波期间,在一家单一中心对艰难梭菌感染(CDI)进行了检测和发病情况检查。尽管抗生素的使用有所增加,但在第一波期间,CDI 的发病率保持稳定,但检测的统计学显著降低。在此期间,没有引入新的针对 CDI 的抗菌药物管理干预措施。